SOX9 binds DNA, activates transcription, and coexpresses with type II collagen during chondrogenesis in the mouse.

Two lines of evidence suggest that the Sry-related gene Sox9 is important for chondrogenesis in mammalian embryos. Sox9 mRNA is expressed in chondrogenic condensations in mice, and mutations in human SOX9 are known to cause skeletal dysplasia. We show here that mouse SOX9 protein is able to bind to a SOX/SRY consensus motif in DNA and contains a modular transcriptional activation domain, consistent with a role for SOX9 as a transcription factor acting on genes involved in cartilage development. One such gene is Col2a1, which encodes type II collagen, the major structural component of cartilage. We have compared, in detail, the expression of Sox9 and Col2a1 during mouse development. In chondrogenic tissues the expression profiles of the two genes were remarkably similar. Coexpression was detected in some nonchondrogenic tissues such as the notochord, otic vesicle, and neural tube, but others such as heart and lung differed in their expression of the two genes. Immunohistochemistry using an antibody specific for SOX9 revealed that expression of SOX9 protein mirrored the distribution of Sox9 mRNA. Our results suggest that SOX9 protein is involved in the regulation of Col2a1 during chondrogenesis, but that this regulation is likely to depend on additional cofactors.

[1]  Y. Kanai,et al.  Identification of two Sox17 messenger RNA isoforms, with and without the high mobility group box region, and their differential expression in mouse spermatogenesis , 1996, The Journal of cell biology.

[2]  E. Vuorio,et al.  Reduced amounts of cartilage collagen fibrils and growth plate anomalies in transgenic mice harboring a glycine-to-cysteine mutation in the mouse type II procollagen alpha 1-chain gene. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[3]  E. Vuorio,et al.  Mouse type II collagen gene. Complete nucleotide sequence, exon structure, and alternative splicing. , 1991, The Journal of biological chemistry.

[4]  R. Derynck,et al.  Toward a molecular understanding of skeletal development , 1995, Cell.

[5]  Tom Maniatis,et al.  Transcriptional activation: A complex puzzle with few easy pieces , 1994, Cell.

[6]  J. Hardelin,et al.  The human SOX11 gene: cloning, chromosomal assignment and tissue expression. , 1995, Genomics.

[7]  N. Svenningsen,et al.  Camptomelic dwarfism. A genetically determined mesenchymal disorder combined with sex reversal. , 2009, Hereditas.

[8]  R. Grosschedl,et al.  LEF‐1 contains an activation domain that stimulates transcription only in a specific context of factor‐binding sites. , 1993, The EMBO journal.

[9]  H. Clevers,et al.  Sox‐4, an Sry‐like HMG box protein, is a transcriptional activator in lymphocytes. , 1993, The EMBO journal.

[10]  R. Tjian,et al.  Analysis of Sp1 in vivo reveals mutiple transcriptional domains, including a novel glutamine-rich activation motif , 1988, Cell.

[11]  J. Rodríguez.  Vascular anomalies in campomelic syndrome. , 1993, American journal of medical genetics.

[12]  G. Muscat,et al.  Sequence and expression of Sox-18 encoding a new HMG-box transcription factor. , 1995, Gene.

[13]  A. Ashworth,et al.  The Sry-related HMG box-containing gene Sox6 is expressed in the adult testis and developing nervous system of the mouse. , 1995, Nucleic acids research.

[14]  K. Cheah,et al.  Preferential expression of alternatively spliced mRNAs encoding type II procollagen with a cysteine-rich amino-propeptide in differentiating cartilage and nonchondrogenic tissues during early mouse development. , 1993, Developmental biology.

[15]  N. Corbi,et al.  Developmental-specific activity of the FGF-4 enhancer requires the synergistic action of Sox2 and Oct-3. , 1995, Genes & development.

[16]  Nicolas Mermod,et al.  A family of human CCAAT-box-binding proteins active in transcription and DNA replication: cloning and expression of multiple cDNAs , 1988, Nature.

[17]  Peter Goodfellow,et al.  A gene mapping to the sex-determining region of the mouse Y chromosome is a member of a novel family of embryonically expressed genes , 1990, Nature.

[18]  B. Howard,et al.  Recombinant genomes which express chloramphenicol acetyltransferase in mammalian cells , 1982, Molecular and cellular biology.

[19]  J. W. Foster,et al.  Mutations in SOX9, the gene responsible for Campomelic dysplasia and autosomal sex reversal. , 1995, American journal of human genetics.

[20]  I. Kaitila,et al.  Identification of COL2A1 gene mutations in patients with chondrodysplasias and familial osteoarthritis. , 1995, Arthritis and rheumatism.

[21]  D. Kravis,et al.  Quantitation of type II procollagen mRNA levels during chick limb cartilage differentiation. , 1985, Developmental biology.

[22]  K. Mark,et al.  Immunological and biochemical studies of collagen type transition during in vitro chondrogenesis of chick limb mesodermal cells , 1977 .

[23]  J. Opitz,et al.  The campomelic syndrome: review, report of 17 cases, and follow-up on the currently 17-year-old boy first reported by Maroteaux et al in 1971. , 1983, American journal of medical genetics.

[24]  Andy Greenfield,et al.  The Sry-related gene Sox9 is expressed during chondrogenesis in mouse embryos , 1995, Nature Genetics.

[25]  J. Strauss,et al.  The "campomelic" syndrome. Short life-span dwarfism with respiratory distress, hypotonia, peculiar facies, and multiple skeletal and cartilaginous deformities. , 1972, A M A Journal of Diseases of Children.

[26]  N. Tommerup,et al.  Autosomal sex reversal and campomelic dysplasia are caused by mutations in and around the SRY-related gene SOX9 , 1994, Cell.

[27]  B. Swalla,et al.  Analysis of type II collagen RNA localization in chick wing buds by in situ hybridization. , 1988, Developmental biology.

[28]  P. Goodfellow,et al.  Sox9 expression during gonadal development implies a conserved role for the gene in testis differentiation in mammals and birds , 1996, Nature Genetics.

[29]  A. Sinclair,et al.  A male-specific role for SOX9 in vertebrate sex determination. , 1996, Development.

[30]  W. Kulyk,et al.  Collagen gene expression during limb cartilage differentiation , 1986, The Journal of cell biology.

[31]  Michael R. Green,et al.  Transcription activation by the adenovirus E1a protein , 1989, Nature.

[32]  M. Ptashne.  How eukaryotic transcriptional activators work , 1988, Nature.

[33]  K. Jones,et al.  The hLEF/TCF-1 alpha HMG protein contains a context-dependent transcriptional activation domain that induces the TCR alpha enhancer in T cells. , 1993, Genes & development.

[34]  Sahar Mansour,et al.  Campomelic dysplasia and autosomal sex reversal caused by mutations in an SRY-related gene , 1994, Nature.

[35]  K. Cheah,et al.  Expression of the mouse alpha 1(II) collagen gene is not restricted to cartilage during development. , 1991, Development.

[36]  P. Goodfellow,et al.  Definition of a consensus DNA binding site for SRY. , 1994, Nucleic acids research.

[37]  J. Scholey.  Kinesin-II, a membrane traffic motor in axons, axonemes, and spindles , 1996, The Journal of cell biology.

[38]  R. Lovell-Badge,et al.  Involvement of SOX proteins in lens‐specific activation of crystallin genes. , 1995, The EMBO journal.

[39]  W. Schaffner,et al.  Rapid detection of octamer binding proteins with 'mini-extracts', prepared from a small number of cells. , 1989, Nucleic acids research.

[40]  G. Muscat,et al.  Trans-activation and DNA-binding properties of the transcription factor, Sox-18. , 1995, Nucleic acids research.

[41]  G. Nabel,et al.  Tumor necrosis factor alpha and interleukin 1 stimulate the human immunodeficiency virus enhancer by activation of the nuclear factor kappa B. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[42]  L. Ala‐Kokko,et al.  Type II collagen mutations in rare and common cartilage diseases. , 1994, Annals of medicine.

[43]  R. Tjian,et al.  Transcriptional regulation in mammalian cells by sequence-specific DNA binding proteins. , 1989, Science.

[44]  J. Barrett,et al.  An amino-terminal c-myc domain required for neoplastic transformation activates transcription , 1990, Molecular and cellular biology.

[45]  A. Ashworth,et al.  An SRY‐related gene expressed during spermatogenesis in the mouse encodes a sequence‐specific DNA‐binding protein. , 1992, The EMBO journal.

[46]  L. Bolund,et al.  Assignment of an autosomal sex reversa– locus (SRA1) and campomelic dysplasia (CMPD1) to 17q24.3–q25.1 , 1993, Nature Genetics.

[47]  H. Helminen,et al.  Transgenic mice with targeted inactivation of the Col2 alpha 1 gene for collagen II develop a skeleton with membranous and periosteal bone but no endochondral bone. , 1995, Genes & development.

[48]  H. Ostrer,et al.  Sry is a transcriptional activator. , 1994, Molecular endocrinology.

[49]  E. Vuorio,et al.  Chondrodysplasia in transgenic mice harboring a 15-amino acid deletion in the triple helical domain of pro alpha 1(II) collagen chain , 1992, The Journal of cell biology.

[50]  P. Sharp,et al.  The B-cell-specific Oct-2 protein contains POU box- and homeo box-type domains. , 1988, Genes & development.

[51]  E. Cartwright,et al.  Embryonic expression of the chicken Sox2, Sox3 and Sox11 genes suggests an interactive role in neuronal development , 1995, Mechanisms of Development.

[52]  L. Ala‐Kokko,et al.  Expression of a partially deleted gene of human type II procollagen (COL2A1) in transgenic mice produces a chondrodysplasia. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[53]  Michihiko Ito,et al.  A rainbow trout SRY‐type gene expressed in pituitary glands , 1995, FEBS letters.

[54]  R. Lovell-Badge,et al.  Expression of a candidate sex-determining gene during mouse testis differentiation , 1990, Nature.

[55]  Gerd Scherer,et al.  Sex reversal by loss of the C–terminal transactivation domain of human SOX9 , 1996, Nature Genetics.